HomeRVV • CNSX
add
Revive Therapeutics Ltd
Previous close
$0.015
Day range
$0.010 - $0.015
Year range
$0.0050 - $0.060
Market cap
3.14M CAD
Avg Volume
639.05K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.86M | -5.30% |
Net income | -1.87M | 3.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.86M | 5.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.05M | -60.48% |
Total assets | 13.14M | -16.64% |
Total liabilities | 3.33M | -15.19% |
Total equity | 9.82M | — |
Shares outstanding | 418.56M | — |
Price to book | 0.75 | — |
Return on assets | -35.67% | — |
Return on capital | -47.44% | — |
Cash Flow
Net change in cash
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -1.87M | 3.71% |
Cash from operations | -1.64M | 24.18% |
Cash from investing | -40.00K | — |
Cash from financing | 2.02M | -50.84% |
Net change in cash | 340.98K | -82.47% |
Free cash flow | -915.05K | 43.70% |
About
Founded
2012
Headquarters
Website
Employees
2